Related by context. All words. (Click for frequent words.) 75 resuscitated cardiac arrest 75 nonfatal myocardial infarction 73 reinfarction 72 myocardial infarction stroke 72 nonfatal stroke 72 recurrent ischemia 71 thrombotic events 70 Erythropoietic therapies may 70 HF hospitalization 70 nonfatal myocardial infarction MI 69 cardiovascular hospitalization 68 CNS systemic embolism 67 periprocedural 67 myocardial infarction MI 67 nonfatal MI 67 cerebrovascular events 66 thromboembolism 66 thromboembolic events 66 cardiovascular hospitalizations 66 silent ischemia 66 recurrent myocardial infarction 66 refractory ischemia 66 coronary revascularization procedures 65 unstable angina pectoris 65 sustained ventricular tachycardia 65 repeat revascularization 65 fatal hemorrhagic 65 coronary revascularization 64 ischemic complications 64 left ventricular dysfunction 64 LV dysfunction 64 ST elevation myocardial 64 arterial thromboembolic events 64 ventricular tachycardia VT 64 ischemic cardiomyopathy 64 urgent coronary revascularization 64 non valvular atrial 64 symptomatic VTE 64 upper gastrointestinal bleeding 64 noncardiovascular mortality 64 myocardial infarction 63 ST Segment Elevation 63 postoperative AF 63 ATACAND 63 ischemia driven 63 thromboembolic 63 ventricular fibrillation VF 63 LVSD 63 myocardial infarctions 63 infarct size 63 intracerebral hemorrhage 63 NSTEMI 63 CHD CVD 63 systemic embolism 63 renal dysfunction 63 cardiovascular mortality 63 coronary stenosis 63 unstable angina UA 63 recurrent venous thromboembolism 63 hyperkalemia 63 composite endpoint 62 stroke transient ischemic 62 recurrent VTE 62 pulmonary embolism PE 62 peri procedural 62 binary restenosis 62 ipsilateral stroke 62 colorectal adenoma 62 severe exacerbations 62 recurrent DVT 62 Severe hypoglycemia 62 PLX STROKE targeting 62 cerebrovascular accident 62 CVD mortality 62 β blockers 62 Myocardial infarction 62 myocardial ischemia 62 fatal IHD 62 hypoglycemic events 62 revascularization procedures 62 CK MB 62 events MACE 62 VT VF 61 LOVENOX 61 fatal pulmonary embolism 61 infarction NSTEMI 61 symptomatic intracranial 61 Primary endpoints 61 cardiac dysfunction 61 TEAEs 61 hypoxemia 61 revascularizations 61 proximal DVT 61 serum triglycerides 61 cardiogenic shock 61 macrovascular events 61 intracerebral haemorrhage 61 β blocker 61 renal insufficiency 61 rhythm disturbances 61 XIENCE V PROMUS Stent 61 extrapyramidal symptoms 61 patients undergoing CABG 61 torsades de pointes 61 aspirin clopidogrel 61 stroke myocardial infarction 61 salmeterol HFA MDI 61 nonischemic 61 pyrexia mucositis sepsis febrile 61 revascularisation 60 antiplatelet drugs 60 thromboembolic complications 60 ischemic cardiovascular 60 mixed hyperlipidemia 60 dysrhythmias 60 VIIBRYD 60 glycated hemoglobin levels 60 Stent thrombosis 60 preserved ejection fraction 60 intracranial hemorrhage ICH 60 hypopneas 60 segment elevation myocardial 60 periprocedural MI 60 hemorrhagic complications 60 microvascular complications 60 decompensated heart failure 60 acute myocardial infarction 60 IIIa inhibitor 60 necrotizing pancreatitis 60 haemorrhagic strokes 60 cerebral perfusion 60 myocardial infarction ventricular fibrillation 60 alcoholic fatty liver 60 angina chest 60 coronary revascularisation 60 cerebral infarction 60 MACCE 60 STEMIs 60 acute coronary 60 pericardial effusion 60 perioperative mortality 60 serum aminotransferase levels 60 intracranial bleeding 60 morphometric vertebral fractures 60 neutrophil counts 60 recurrent ischemic 60 cardioembolic 60 sotalol 60 serum phosphorous 60 definite stent thrombosis 60 Events MACE 60 serum creatinine levels 60 nonfatal pulmonary embolism 60 nondiabetic patients 60 atherothrombotic disease 59 tachyarrhythmias 59 contrast induced nephropathy 59 KIF6 carriers 59 ventricular arrhythmia 59 postoperative morbidity 59 variceal 59 left ventricular systolic 59 syncopal 59 Hypotension 59 atrioventricular block 59 nonfasting triglycerides 59 lipoprotein Lp 59 nonfasting triglyceride levels 59 eplerenone 59 QTc prolongation 59 beta blocker therapy 59 triglyceride TG 59 coagulopathy 59 death reinfarction 59 thrombotic complications 59 angina myocardial infarction 59 carotid stenosis 59 calcified plaques 59 hematologic adverse 59 rosuvastatin #mg 59 hypercholesterolaemia 59 acute myocardial infarction AMI 59 perioperative complications 59 Unstable Angina 59 cerebral infarctions 59 venous thromboembolic disease 59 lipid lowering agents 59 electrolyte abnormalities 59 aldosterone antagonist 59 hepatic failure 59 rebleeding 59 intracerebral hemorrhages 59 postoperative mortality 59 cerebrovascular accidents 59 unstable angina 59 Unstable angina 59 dose atorvastatin 59 nonfatal cardiovascular 59 ischemic 59 tHcy 59 cardioembolic stroke 59 angina pectoris 59 undergoing coronary angiography 59 NATRECOR ® 59 DVT PE 59 hypokalemia 59 Ischemic stroke 59 thrombocytopenic 59 infarctions 59 atherothrombotic 59 postoperative complication 59 haemorrhagic stroke 58 fractional shortening 58 mL/min/#.# m 2 58 calculated creatinine clearance 58 macrovascular disease 58 torsade de pointes 58 myocardial infraction 58 angiotensin converting enzyme inhibitors 58 NYHA Class II 58 neutropenia dehydration dyspnea 58 valvular disease 58 urgent revascularization 58 benazepril 58 ketoacidosis hyperosmolar coma 58 cardiovascular morbidity 58 paclitaxel eluting stents 58 fasting triglycerides 58 #.#/#.# mmHg [001] 58 inhospital 58 afterload 58 sirolimus eluting stents 58 hypervolemic hyponatremia 58 macrovascular 58 noncardiac 58 tirofiban 58 thiazide diuretic 58 CrCl 58 hyperglycaemia 58 Cardiopulmonary bypass 58 Hemorrhagic stroke 58 acute coronary syndrome 58 myocardial ischaemia 58 QTc intervals 58 severe hypoglycemia 58 antihypertensive medications 58 acute decompensation 58 cerebral ischemia 58 TAXUS Express Stent 58 proliferative diabetic retinopathy 58 Uncontrolled hypertension 58 anticoagulants blood thinners 58 hypovolemia 58 supraventricular arrhythmias 58 hepatotoxicity 58 familial AF 58 cytopenias 58 deep venous thromboses 58 TMP SMX 58 cardiogenic pulmonary edema 58 bypass graft CABG surgery 58 target lesion revascularization 58 intracranial haemorrhage 58 ARIXTRA 58 HMG CoA reductase inhibitors 58 MIs 58 pulmonary embolus 58 cerebral vascular 58 severe hypoglycemic 58 hematologic toxicity 58 PRADAXA #mg 58 acute myocardial infarction MI 58 hypoventilation 58 hepatorenal syndrome 58 fibrinolysis 58 BENICAR HCT 58 nontraumatic 58 decompensation 58 Hb A1C 58 NATRECOR R 58 nadolol 58 hyperhomocysteinemia 58 ABCB1 58 myocardial infarctions MIs 58 adrenal insufficiency 58 Thal Dex 58 prolonged QT interval 58 Endothelial dysfunction 58 mild renal insufficiency 58 metabolic acidosis 57 de ath 57 carotid artery blockage 57 Torsades de Pointes 57 STRIDE PD 57 nicardipine 57 everolimus eluting stents 57 Exacerbations 57 density lipoprotein cholesterol 57 Ischemic 57 stable angina 57 serum potassium 57 mmHg diastolic 57 UA NSTEMI 57 coronary intervention 57 Thrombolysis 57 ximelagatran 57 Primary Hypercholesterolemia 57 clinically meaningful reductions 57 renal artery stenosis 57 secondary efficacy endpoint 57 intraventricular hemorrhage 57 apo B 57 apnea hypopnea index 57 baseline serum creatinine 57 intima media thickness 57 oral hypoglycemic agents 57 fluid overload 57 microvascular disease 57 Hemorrhagic strokes 57 thyrotoxicosis 57 ventricular tachyarrhythmia 57 thyrotropin levels 57 infarction STEMI 57 Atherosclerotic 57 echocardiographic parameters 57 systolic dysfunction 57 potassium sparing diuretics 57 antithrombotic therapies 57 noncardiovascular 57 ID TLR 57 bleeding ulceration 57 unfractionated heparin UFH 57 hypoglycemic episodes 57 variant angina 57 thrombolytic therapy 57 BYSTOLIC 57 IPAH 57 ejection fractions 57 LVEF 57 intracranial atherosclerosis 57 aspartate aminotransferase AST 57 glomerular filtration rate 57 reoperations 57 multivariate adjustment 57 proteinuria 57 vertebral fracture 57 metoprolol tartrate 57 antithrombotic therapy 57 thrombocytosis 57 serum triglyceride levels 57 hemorrhagic strokes 57 pulmonary capillary wedge 57 hypophosphatemia 57 severe renal insufficiency 57 undergoing coronary artery 57 corticosteroid dose 57 diastolic BP 57 ADHF 57 convulsive seizures 57 albumin excretion rate 57 cerebral vasospasm 57 apnea hypopnea 57 Orthostatic hypotension 57 venous thromboembolisms 57 concomitant medications 57 Postoperative complications 57 Proteinuria 57 carotid atherosclerosis 57 nephrotoxicity 57 lumiracoxib 57 del 5q MDS 57 hypotension 57 EXJADE 57 Renal dysfunction 57 glycosylated hemoglobin HbA1c 57 atrophic gastritis 57 oxycodone CR 57 myopathy rhabdomyolysis 57 drug eluting stent implantation 57 CABG coronary artery 57 antiplatelet medications 57 NNT = 57 primidone 57 IOP lowering 57 XIENCE V demonstrated 57 Microalbuminuria 57 liver transplant recipients 57 acute ischemic 57 tumor lysis syndrome 57 bacterial prostatitis 57 nonsignificant 57 natriuresis 57 anticoagulant warfarin 57 sternal wound infection 57 angiotensin converting enzyme inhibitor 57 fraction LVEF 57 intraoperative complications 57 dizziness nausea diarrhea 56 venous thrombosis 56 plus GP IIb 56 Pulmonary hypertension 56 CYPHER ® 56 acute myocardial infarctions 56 coronary blockages 56 sirolimus stent 56 neonatal morbidity 56 polyp recurrence 56 Myocardial Infarction MI 56 target vessel revascularization 56 hypertension congestive heart 56 elevated ALT 56 troponin T 56 glomerular filtration 56 symptomatic pulmonary embolism 56 leucopenia 56 STEMI 56 serum urate 56 neurodevelopmental impairment 56 baseline HbA1c 56 serum glucose 56 Pioglitazone 56 irbesartan 56 Ventricular tachycardia 56 Coronary Artery Bypass Graft 56 venous thromboembolic events 56 pulmonary exacerbations 56 Acute myocardial infarction 56 cirrhotic patients 56 neurologic complications 56 hypertensives 56 subclinical hypothyroidism 56 peripheral arterial occlusive disease 56 serum leptin 56 bivalirudin 56 lactate dehydrogenase LDH 56 revascularization procedure 56 thiazide diuretics 56 stenoses 56 perindopril 56 NIDDM 56 postoperative infections 56 systemic hypotension 56 coronary heart 56 arrythmias 56 thrombogenic 56 macrovascular complications 56 cardiac tamponade 56 HOMA IR 56 total cholesterol triglycerides 56 hypovolemic 56 hemodynamic instability 56 aminotransferases 56 acute coronary syndromes ACS 56 Secondary endpoints included 56 generalized edema 56 ischemic stroke 56 NPH insulin 56 p = #.# [003] 56 COPD exacerbations 56 systolic BP 56 cryptogenic 56 metabolic alkalosis 56 variceal bleeding 56 homocysteine concentrations 56 thrombus aspiration 56 neointimal hyperplasia 56 ischemic heart 56 cerebrovascular disease 56 albuminuria 56 elevation acute coronary 56 Nesiritide 56 % CI #.#-#.# [006] 56 myocardial infarct 56 obstructive CAD 56 advanced adenomas 56 #mm Hg 56 cirrhotic 56 triglycerides TG 56 Diabetic nephropathy 56 angiotensin II receptor blockers 56 androgen deprivation 56 preserved systolic 56 patients undergoing percutaneous 56 vasospasm 56 postural hypotension 56 lacunar 56 elevated triglyceride levels 56 transferrin saturation 56 artery occlusion 56 anticoagulation therapy 56 carotid IMT 56 labetalol 56 lethal arrhythmias 56 NIASPAN 56 bypass grafting 56 serum parathyroid hormone 56 Coronary artery bypass grafting 56 beta blockers ACE inhibitors 56 chronic thromboembolic pulmonary 56 microbleeds 56 induce orthostatic hypotension 56 salmeterol fluticasone propionate 56 elevated LDH 56 thromboses 56 lipid lowering drugs 56 abdominal adiposity 56 oral anticoagulation therapy 56 valsartan 56 deep vein thromboses 56 neutropenic patients 56 recurrent atrial fibrillation 56 myocardial reperfusion 56 angiographic restenosis 56 bronchial hyperresponsiveness 56 antiarrhythmic medications 56 TAXUS p value 56 doxorubicin docetaxel 56 Angiograms carry slight 56 #mmHg [001] 56 ARCOXIA 56 triglyceride concentration 56 laboratory abnormalities 56 ocular adverse 56 HAM D# scores 56 loop diuretics 56 salmeterol fluticasone 56 fibrinolytic therapy 56 PSA nadir 56 % CI #.#-#.# [004] 56 confidence interval #.#-#.# 56 rehospitalization 56 asthma exacerbation 56 LV ejection fraction 56 inotropic agents 56 thrombolytic agents 56 gastrointestinal perforation 56 pancreatectomy 56 Lactic acidosis 56 postoperative atrial fibrillation 56 gastrointestinal hemorrhage 56 hydroxymethyl coenzyme 56 multivessel disease 56 creatine kinase MB 55 ventricular tachyarrhythmias 55 cholesterol LDL C 55 serum calcium 55 hypopnea 55 INTEGRILIN R 55 NSTE ACS 55 bone marrow reticulin 55 UACR 55 plasma triglycerides 55 COPD exacerbation 55 coronary stenoses 55 transaminase elevations 55 apolipoprotein B 55 multivariate Cox 55 adjunctive ABILIFY 55 embolic stroke 55 asystole 55 serum uric acid 55 sinus tachycardia 55 liver decompensation 55 alanine aminotransferase 55 percutaneous transluminal coronary angioplasty 55 symptom exacerbation 55 thromboprophylaxis 55 Hyperlipidemia 55 highest tertile 55 arterial revascularization 55 unfractionated heparin 55 eptifibatide 55 spontaneous preterm delivery 55 nonvertebral fracture 55 diastolic blood pressures 55 coronary interventions 55 moderate renal impairment 55 alcoholic cirrhosis 55 neurologic outcomes 55 nondiabetics 55 dyslipidemia hypertension 55 Asymptomatic 55 TYSABRI treated 55 bivalirudin monotherapy 55 nadroparin 55 Pulmonary embolism 55 onset atrial fibrillation 55 postprocedure 55 rFVIIa 55 lopinavir r arm 55 ischemic strokes 55 fondaparinux 55 anaphylactoid reactions 55 hematological adverse 55 Febrile neutropenia 55 estimated glomerular filtration 55 AVANDIA 55 tolvaptan 55 GP IIb IIIa inhibitors 55 candesartan cilexetil 55 hypovolemic shock 55 Percutaneous Coronary Intervention 55 locoregional recurrence 55 Ramipril 55 ICD shocks 55 ventricular remodeling 55 urinary cortisol 55 Tasigna prolongs 55 airflow limitation 55 Venous thromboembolism 55 antiarrhythmic drug 55 comorbid conditions 55 hypertension diabetes mellitus 55 creatinine clearance 55 atherothrombotic events 55 symptomatic intracranial hemorrhage 55 Kaplan Meier estimates 55 CRESTOR #mg 55 Prehypertension 55 gastrointestinal GI bleeding 55 HbA 1c 55 gastrointestinal adverse reactions 55 adjunctive placebo 55 PSADT 55 tenecteplase 55 antiplatelet agent 55 progressive dyspnea 55 somnolence dizziness 55 lipid lowering medications 55 #.#mmHg 55 lipid lowering medication 55 Carotid Revascularization Endarterectomy vs. 55 discontinuations due 55 Radical prostatectomy 55 arterial occlusion 55 revascularization 55 bivalirudin alone 55 intracerebral 55 infective endocarditis 55 receiving VELCADE 55 cardiovascular disease hypertension 55 lowest tertile 55 renal scarring 55 symptomatic hyponatremia 55 NIHSS score 55 nonhematologic adverse reactions 55 revascularized 55 hyperpyrexia 55 hemodilution 55 NMIBC 55 hepatic function 55 autonomic dysfunction 55 antiarrhythmic drugs 55 STEMI ST 55 serum calcium levels 55 distal embolization thrombus formation 55 mucocutaneous reactions 55 renal impairment 55 dysfunction LVSD 55 hip BMD 55 recurrent stroke 55 x ULN 55 clopidogrel 55 fatal arrhythmic 55 mitral insufficiency 55 pressure tachycardia diaphoresis 55 mcg QD 55 obstructive coronary 55 coronary 55 arterial calcification 55 oxycodone IR 55 Subarachnoid hemorrhage 55 bradycardia 55 oral antidiabetic medication 55 HbA1C levels 55 aneurysm rupture 55 BENICAR 55 rhythm abnormalities 55 elevated LDL cholesterol 55 Operative mortality 55 pretest probability 55 subarachnoid hemorrhages 55 lispro 55 advanced adenoma 55 interstitial pneumonitis 55 Abbott Trilipix 55 severe hypersensitivity reactions 55 nesiritide 55 Exacerbation 55 hepatic impairment 55 ACTOplus met XR 55 urinary oxalate 55 plus glycoprotein IIb 55 intraoperative bleeding 55 reintervention 55 ertapenem 55 elevated fasting glucose 55 acute cholecystitis 55 dermatologic reactions 55 Arrhythmogenic Right Ventricular Cardiomyopathy 55 syncope 55 ß blockers 55 subarachnoid haemorrhage 55 HDL C 55 NSAID associated 55 VTE 55 aneurysm ruptures 55 haematological toxicity 55 endarterectomy 55 hypercalcaemia 55 severe renal impairment 55 serum bilirubin 55 P = .# 55 eicosapentaenoic acid 55 coronary thrombosis 55 left ventricular hypertrophy 55 distensibility 55 onset diabetes mellitus 55 ticlopidine 55 aldosterone antagonists 55 hypercalcemia 55 fasting glucose levels 55 See WARNINGS 55 carotid bruit 55 primary percutaneous coronary 55 mg BID dose 55 QT prolongation 55 Abciximab 55 CsA 55 Kaplan Meier analysis 55 elevated IOP 55 overt nephropathy 55 DULERA 55 nasopharyngitis headache 55 valvular heart disease 55 prospectively stratified 55 Fasting plasma glucose 55 coronary artery disease 55 descending thoracic 55 arterial inflammation 55 Tranexamic acid 55 ventricular dysfunction 55 gallbladder disease 55 morbidity mortality 55 Celecoxib APC trial 55 intra abdominal abscess 54 prespecified secondary 54 dysglycemia 54 histologic subtype 54 hepatic dysfunction 54 cilostazol 54 QTc interval 54 APTIVUS r 54 SGPT 54 myocardial fibrosis 54 syncope fainting 54 ACE Inhibitor 54 platelet reactivity 54 occlusive disease 54 creatinine ratio 54 NOLVADEX 54 apolipoprotein E4 54 metformin accumulation 54 glycated hemoglobin HbA1c 54 Statin therapy 54 SSc 54 leiomyomas 54 intravascular hemolysis 54 recurrent coronary 54 fatal arrhythmias 54 ALT elevation 54 malperfusion 54 nonfatal cardiac arrest 54 Intracerebral hemorrhage 54 Postoperative 54 hematological toxicities 54 fasting insulin 54 urate lowering 54 STEMI patients 54 acid suppressive medication 54 hyperacute 54 intravenous diuretics 54 Ranolazine 54 MULTAQ 54 atheroma 54 hepatic insufficiency 54 Warfarin Coumadin 54 thrombotic 54 CI #.#-#.# [001] 54 myocardial viability 54 antiphospholipid syndrome 54 carotid plaque 54 NYHA Class III 54 coronary artery occlusion 54 Atrial fibrillation AF 54 bezafibrate 54 paroxysmal supraventricular tachycardia 54 post thrombotic syndrome 54 intravitreal injections 54 anticoagulant medications 54 cystatin C 54 Serious adverse reactions 54 contrast echocardiography 54 cancerous enlargement 54 hyperphenylalaninemia HPA due 54 olmesartan 54 aminotransferase ALT 54 mm Hg systolic 54 acutely decompensated congestive heart 54 CYPHER Stent 54 Atrial flutter 54 untreated OSA 54 mycophenolate mofetil 54 renal function 54 diabetic kidney 54 euvolemic 54 heparin induced thrombocytopenia 54 capillary leak 54 infliximab monotherapy 54 atherosclerotic disease 54 fosamprenavir 54 angiographically 54 acute coronary syndromes 54 endometrial hyperplasia 54 chlorthalidone 54 Infarction 54 Acute coronary syndromes 54 ACEI ARB 54 atherothrombosis 54 cerebral oxygenation 54 euvolemic hyponatremia 54 inotropic 54 Hypoglycemia 54 postoperative complications 54 ACTOplus met 54 umol L 54 unknown etiology 54 mEq L 54 recurrent glioblastoma multiforme 54 artery stenosis 54 hypoglycemia 54 cerebral oxygen saturation 54 strong CYP#A# inducers 54 verapamil 54 CV thrombotic 54 hypoperfusion 54 diabetes mellitus hypertension 54 severe neutropenia 54 Lp PLA2 54 fluvastatin 54 prednisone prednisolone plus 54 cTnI 54 thioridazine 54 neurologic sequelae 54 death dissection perforation 54 stent implantation 54 haloperidol Haldol 54 anemia hemoglobin 54 Cardiogenic shock 54 severe asthma exacerbations 54 corticosteroid therapy 54 nonvertebral fractures 54 atherogenic dyslipidemia 54 coadministration 54 hemodynamic parameters 54 vascular inflammation 54 erythropoietic 54 lightheadedness fainting 54 arterial oxygen saturation 54 AGGRASTAT ® tirofiban hydrochloride 54 dyslipidaemia 54 cryptogenic stroke 54 BSIs 54 cholecystitis 54 Diastolic 54 airway obstruction bronchospasm stridor 54 bronchopulmonary dysplasia 54 fibrinolytic 54 serum estradiol 54 otamixaban 54 Non Alcoholic Fatty 54 Secondary efficacy endpoints 54 Heavy snorers 54 Hazard Ratio 54 Major Adverse Cardiac 54 administered erythropoiesis stimulating 54 elevated serum creatinine 54 Ischemic strokes 54 myocardial infarction congestive heart 54 carotid artery narrowing 54 liver metastasis 54 fasting triglyceride levels 54 triglyceride concentrations 54 mL/min/#.# m2 54 Secondary endpoints include 54 ug dose 54 headache nasopharyngitis 54 androgen suppression 54 confidence interval CI 54 OPCAB 54 lipid lowering therapy 54 elevated creatinine 54 angioplasties stents 54 QTc 54 omeprazole Prilosec 54 NSAID induced GI 54 carotid intima media 54 thromboembolic disease 54 serum triglyceride 54 CIMZIA ™ 54 fatal anaphylactic 54 cTnT 54 congestive cardiac 54 cardiovascular calcification 54 Secondary endpoints 54 catheter angiography 54 LDB CPR 54 nonfasting 54 generalized tonic clonic seizures 54 impaired hepatic 54 traumatic amputations 54 hyperlipidaemia 54 anticoagulation 54 cerebrovascular 54 coronary disease 54 defibrillator CRT D 54 urine albumin 54 hemoglobin A1c HbA1c 54 nmol liter 54 stent thromboses 54 salmeterol inhalation powder 54 univariate 54 ECG abnormalities 54 tamoxifen Nolvadex ® 54 vein thrombosis 54 systemic corticosteroid 54 CABG surgery 54 venous thrombotic events 54 COREG 54 events thrombocytopenia neutropenia 54 mechanically ventilated patients 54 insulin secretagogue 54 nonsevere 54 arterial embolism 54 cyclophosphamide methotrexate 54 TT genotype 54 normothermia 54 suppurative 54 neurologic dysfunction 54 Restenosis 54 amenorrhoea 54 nonrandomized 54 drotrecogin alfa activated 54 colorectal adenomas 54 underwent coronary angiography 54 obstructive coronary artery 54 tachyarrhythmia 54 platelet activation 54 HIV HCV coinfected 54 antidiabetic medication 54 D dimer 54 hypercapnia 54 prospectively defined 54 repeat paracentesis 54 cardiopulmonary bypass CPB 54 gastrointestinal GI motility disorders 54 bacteriuria 54 thienopyridines 54 HbA1c levels 54 intracranial stenosis 54 cerebral embolism 54 Renal impairment 54 AST ALT 54 thrombus formation 54 microemboli 54 serum phosphorus 54 multisystem organ failure 54 veno occlusive disease 54 #mg/dl 54 postoperative pulmonary 54 multivariable analysis 54 percutaneous intervention 54 oxygen desaturation 54 receiving XGEVA 54 Ischaemic 54 Untreated sleep apnea 54 adenoma recurrence 54 intravenous bisphosphonates 54 CHD mortality 54 Fasting blood glucose 54 Acute Coronary Syndrome 54 VTEs 54 impaired renal 54 QTcF 54 esophagogastric 54 aneurysmal subarachnoid hemorrhage 54 Acute Myocardial Infarction 54 subgroup analyzes 54 hemoglobin Hb